Sirio Pharma (300791)

Currency in CNY
16.80
-0.01(-0.06%)
Delayed Data·
300791 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
16.7016.98
52 wk Range
15.4026.17
Key Statistics
Bid/Ask
16.78 / 16.81
Prev. Close
16.81
Open
16.98
Day's Range
16.7-16.98
52 wk Range
15.4-26.17
Volume
607.32K
Average Volume (3m)
2.09M
1-Year Change
-32.5301%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
300791 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
23.00
Upside
+36.90%
Members' Sentiments
Bearish
Bullish
ProTips
Has maintained dividend payments for 7 consecutive years

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 23.00
(+36.90% Upside)

Earnings

Latest Release
Oct 26, 2026
EPS / Forecast
-- / --
Revenue / Forecast
1.01B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.35
Dividend Yield
0.77%
Industry Median 2.64%
Annualised payout
0.13
Paid annually
5-Years Growth
-11.29%
Growth Streak

300791 Income Statement

Compare 300791 to Peers and Sector

Metrics to compare
300791
Peers
Sector
Relationship
P/E Ratio
48.6x22.1x10.6x
PEG Ratio
−0.710.290.03
Price/Book
1.7x2.0x1.5x
Price / LTM Sales
1.3x2.0x0.8x
Upside (Analyst Target)
36.7%10.3%23.3%
Fair Value Upside
Unlock14.0%14.4%Unlock

Sirio Pharma Co., Ltd. operates as a contract manufacturer for dietary supplement industry China, the United States, Europe, and internationally. The company develops and manufactures a range of softgel dietary supplements; vegetarian softgel; nutritious gummies; liquids; probiotic balls; tablet and powder products; capsules; and functional beverages for beauty and wellness, gut health, bone and joint health, immune and fertility support, cardiovascular and metabolic health, and healthy ageing. It also offers formulation; technical, and research and development support; and primary and final packaging services. Sirio Pharma Co., Ltd. was founded in 1993 and is headquartered in Shantou, China.

Employees
2776
Market
China

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
27.65M9.01%472.29M
Other Institutional Investors
177.19M57.71%3.03B
Public Companies & Retail Investors
102.18M33.28%1.75B
Total
307.02M100.00%5.24B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Guangdong Guanghui Investment Co., Ltd.42.80%131,414,4002,244,558
Shanghai Orient Securities Asset Management Co., Ltd.2.51%7,695,300131,436

FAQ

What Is the Sirio Pharma (300791) Stock Price Today?

The Sirio Pharma stock price today is 16.80 CNY.

What Stock Exchange Does Sirio Pharma Trade On?

Sirio Pharma is listed and trades on the Shenzhen Stock Exchange.

What Is the Stock Symbol for Sirio Pharma?

The stock symbol for Sirio Pharma is "300791."

What Is the Sirio Pharma Market Cap?

As of today, Sirio Pharma market cap is 5.16B CNY.

What Is Sirio Pharma's Earnings Per Share (TTM)?

The Sirio Pharma EPS (TTM) is 0.35.

From a Technical Analysis Perspective, Is 300791 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Sirio Pharma Stock Split?

Sirio Pharma has split 4 times.

How Many Employees Does Sirio Pharma Have?

Sirio Pharma has 2776 employees.

What is the current trading status of Sirio Pharma (300791)?

As of Nov 10, 2026, Sirio Pharma (300791) is trading at a price of 16.80 CNY, with a previous close of 16.81 CNY. The stock has fluctuated within a day range of 16.70 CNY to 16.98 CNY, while its 52-week range spans from 15.40 CNY to 26.17 CNY.

What Is Sirio Pharma (300791) Price Target According to Analysts?

The average 12-month price target for Sirio Pharma is 23.00 CNY, with a high estimate of 23 CNY and a low estimate of 23 CNY. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +36.90% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.